$BGNE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BeiGene, Ltd.. Get notifications about new insider transactions in BeiGene, Ltd. for free.
Page: < prev 1 ... 3 4 5 6 7 8 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 100.08 | 1,000 | 100,080 | 99,000 | 100 K to 99 K (-1.00 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 99.05 | 200 | 19,810 | 100,000 | 100.2 K to 100 K (-0.20 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 97.83 | 1,700 | 166,317 | 100,200 | 101.9 K to 100.2 K (-1.67 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.68 | 8,279 | 800,398 | 101,900 | 110.2 K to 101.9 K (-7.51 %) |
| Dec 28 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 95.55 | 8,958 | 855,910 | 110,179 | 119.1 K to 110.2 K (-7.52 %) |
| Dec 22 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 13,000 | 29,510 | 1,367,500 | |
| Dec 22 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 98.00 | 1,000 | 98,000 | 0 | 1,000 to 0 (-100.00 %) |
| Dec 22 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.51 | 1,000 | 29,510 | 1,000 | 0 to 1,000 |
| Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 1,380,500 | |
| Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 94.53 | 200 | 18,906 | 0 | 200 to 0 (-100.00 %) |
| Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 94.21 | 1,300 | 122,475 | 200 | 1.5 K to 200 (-86.67 %) |
| Dec 15 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.51 | 1,500 | 44,265 | 1,500 | 0 to 1.5 K |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.67 | 4,800 | 464,022 | 119,137 | 123.9 K to 119.1 K (-3.87 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 95.62 | 37,208 | 3,557,885 | 123,937 | 161.1 K to 123.9 K (-23.09 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 94.91 | 10,809 | 1,025,851 | 161,145 | 172 K to 161.1 K (-6.29 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.66 | 100 | 9,666 | 171,954 | 172.1 K to 172 K (-0.06 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 96.12 | 5,162 | 496,175 | 172,054 | 177.2 K to 172.1 K (-2.91 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 94.98 | 7,743 | 735,434 | 177,216 | 185 K to 177.2 K (-4.19 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.94 | 13,213 | 1,241,236 | 184,959 | 198.2 K to 185 K (-6.67 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.23 | 9,439 | 880,030 | 198,172 | 207.6 K to 198.2 K (-4.55 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 92.06 | 24,080 | 2,216,764 | 207,611 | 231.7 K to 207.6 K (-10.39 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.96 | 1,400 | 131,537 | 231,691 | 233.1 K to 231.7 K (-0.60 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 93.02 | 4,000 | 372,090 | 233,091 | 237.1 K to 233.1 K (-1.69 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 92.36 | 18,046 | 1,666,794 | 237,091 | 255.1 K to 237.1 K (-7.07 %) |
| Dec 08 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 91.48 | 8,000 | 731,803 | 255,137 | 263.1 K to 255.1 K (-3.04 %) |
| Dec 05 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 86.00 | 1,100 | 94,600 | 0 | 1.1 K to 0 (-100.00 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 82.92 | 36,340 | 3,013,458 | 263,137 | 299.5 K to 263.1 K (-12.13 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 85.52 | 32,985 | 2,820,864 | 299,477 | 332.5 K to 299.5 K (-9.92 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 87.49 | 235 | 20,560 | 332,462 | 332.7 K to 332.5 K (-0.07 %) |
| Nov 29 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 86.75 | 16,346 | 1,418,022 | 332,697 | 349 K to 332.7 K (-4.68 %) |
| Nov 20 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 87.00 | 1,000 | 87,000 | 1,100 | 2.1 K to 1.1 K (-47.62 %) |
| Nov 20 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 85.00 | 600 | 51,000 | 2,100 | 2.7 K to 2.1 K (-22.22 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 80.84 | 100 | 8,084 | 349,043 | 349.1 K to 349 K (-0.03 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 80.29 | 62,170 | 4,991,791 | 349,143 | 411.3 K to 349.1 K (-15.12 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 79.16 | 3,798 | 300,633 | 411,313 | 415.1 K to 411.3 K (-0.91 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 81.00 | 100 | 8,100 | 415,111 | 415.2 K to 415.1 K (-0.02 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 80.10 | 20,407 | 1,634,501 | 415,211 | 435.6 K to 415.2 K (-4.68 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 79.55 | 39,328 | 3,128,350 | 435,618 | 474.9 K to 435.6 K (-8.28 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 84.04 | 100 | 8,404 | 474,946 | 475 K to 474.9 K (-0.02 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 83.24 | 16,845 | 1,402,136 | 475,046 | 491.9 K to 475 K (-3.42 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 82.67 | 8,109 | 670,376 | 491,891 | 500 K to 491.9 K (-1.62 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 83.31 | 1,201 | 100,054 | 0 | 1.2 K to 0 (-100.00 %) |
| Nov 15 2017 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 82.79 | 2,400 | 198,693 | 1,201 | 3.6 K to 1.2 K (-66.65 %) |
| Oct 16 2017 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 7,102 | 0 | 7,102 | 0 to 7.1 K |
| Oct 16 2017 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 7,102 | 0 | 7,102 | 0 to 7.1 K |
| Oct 16 2017 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 49,200 | 0 | 0 | 49.2 K to 0 (-100.00 %) |
| Oct 02 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Option Exercise | A | 7.70 | 935,000 | 7,199,500 | 935,000 | |
| Oct 02 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Grant | A | 0.00 | 515,000 | 0 | 21,745,525 | 21.2 M to 21.7 M (+2.43 %) |
| Oct 02 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Option Exercise | A | 7.70 | 750,000 | 5,775,000 | 750,000 | |
| Oct 02 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Grant | A | 0.00 | 410,000 | 0 | 12,935,393 | 12.5 M to 12.9 M (+3.27 %) |
| Aug 24 2017 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Payment of Exercise | F | 5.39 | 28,185 | 151,830 | 271,815 | 300 K to 271.8 K (-9.39 %) |
| Aug 14 2017 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 71.00 | 158,279 | 11,237,809 | 3,476,256 | 3.3 M to 3.5 M (+4.77 %) |
| Aug 14 2017 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 71.00 | 17,777 | 1,262,167 | 372,975 | 355.2 K to 373 K (+5.00 %) |
| Jul 13 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 73.22 | 799 | 58,499 | 0 | 799 to 0 (-100.00 %) |
| Jul 13 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 72.58 | 15,501 | 1,125,032 | 799 | 16.3 K to 799 (-95.10 %) |
| Jul 13 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 71.67 | 3,700 | 265,174 | 16,300 | 20 K to 16.3 K (-18.50 %) |
| Jul 12 2017 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Gift | G | 0.00 | 175,682 | 0 | 4,565,794 | 4.7 M to 4.6 M (-3.71 %) |
| Jul 12 2017 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 72.36 | 7,206 | 521,450 | 0 | 7.2 K to 0 (-100.00 %) |
| Jul 12 2017 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 71.71 | 3,604 | 258,450 | 7,206 | 10.8 K to 7.2 K (-33.34 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 68.11 | 300 | 20,433 | 0 | 300 to 0 (-100.00 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 67.36 | 3,071 | 206,865 | 300 | 3.4 K to 300 (-91.10 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 66.35 | 51,821 | 3,438,256 | 3,371 | 55.2 K to 3.4 K (-93.89 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 65.42 | 64,553 | 4,222,889 | 55,192 | 119.7 K to 55.2 K (-53.91 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 64.51 | 44,695 | 2,883,234 | 119,745 | 164.4 K to 119.7 K (-27.18 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 63.63 | 30,390 | 1,933,770 | 164,440 | 194.8 K to 164.4 K (-15.60 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 62.57 | 10,324 | 646,015 | 194,830 | 205.2 K to 194.8 K (-5.03 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 61.50 | 6,901 | 424,380 | 205,154 | 212.1 K to 205.2 K (-3.25 %) |
| Jul 10 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 60.62 | 7,345 | 445,282 | 212,055 | 219.4 K to 212.1 K (-3.35 %) |
| Jun 30 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 45.53 | 6,600 | 300,500 | 20,000 | 26.6 K to 20 K (-24.81 %) |
| Jun 30 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 44.82 | 28,400 | 1,272,845 | 26,600 | 55 K to 26.6 K (-51.64 %) |
| Jun 29 2017 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Option Exercise | A | 3.49 | 1,016,178 | 3,546,461 | 1,016,178 | |
| Jun 29 2017 | BGNE | BeiGene, Ltd. | Li Ji | EVP and Gl. Head of ... | Option Exercise | A | 3.49 | 750,000 | 2,617,500 | 750,000 | |
| Jun 29 2017 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & CSO | Option Exercise | A | 3.46 | 1,250,000 | 4,325,000 | 1,250,000 | |
| Jun 29 2017 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 3.49 | 980,465 | 3,421,823 | 980,465 | |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 45.73 | 4,500 | 205,786 | 46,840 | 51.3 K to 46.8 K (-8.77 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 44.62 | 10,981 | 490,001 | 51,340 | 62.3 K to 51.3 K (-17.62 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 43.85 | 24,414 | 1,070,566 | 62,321 | 86.7 K to 62.3 K (-28.15 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 44.78 | 1,800 | 80,611 | 86,735 | 88.5 K to 86.7 K (-2.03 %) |
| Jun 26 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 44.06 | 56,805 | 2,502,658 | 88,535 | 145.3 K to 88.5 K (-39.08 %) |
| Jun 06 2017 | BGNE | BeiGene, Ltd. | Chen Timothy Yung-Cheng | Director | Option Exercise | A | 3.16 | 169,988 | 537,162 | 169,988 | |
| Jun 06 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Gift | G | 0.00 | 9,841 | 0 | 224,372 | 214.5 K to 224.4 K (+4.59 %) |
| Jun 06 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Gift | G | 0.00 | 19,682 | 0 | 12,505,711 | 12.5 M to 12.5 M (-0.16 %) |
| Jun 06 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 40.00 | 5,539 | 221,560 | 55,000 | 60.5 K to 55 K (-9.15 %) |
| Jun 06 2017 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 3.16 | 169,988 | 537,162 | 169,988 | |
| May 05 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 41.01 | 4,491 | 184,171 | 60,539 | 65 K to 60.5 K (-6.91 %) |
| May 05 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 40.71 | 9,970 | 405,871 | 65,030 | 75 K to 65 K (-13.29 %) |
| May 01 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 42.02 | 2,100 | 88,243 | 145,340 | 147.4 K to 145.3 K (-1.42 %) |
| May 01 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.37 | 34,049 | 1,374,565 | 147,440 | 181.5 K to 147.4 K (-18.76 %) |
| Apr 21 2017 | BGNE | BeiGene, Ltd. | Yi Qingqing | Director | Option Exercise | A | 2.84 | 199,992 | 567,977 | 199,992 | |
| Apr 21 2017 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Option Exercise | A | 2.84 | 199,992 | 567,977 | 199,992 | |
| Apr 21 2017 | BGNE | BeiGene, Ltd. | Tang Ke | Director | Option Exercise | A | 2.84 | 199,992 | 567,977 | 199,992 | |
| Apr 21 2017 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 2.84 | 399,984 | 1,135,955 | 399,984 | |
| Apr 07 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 37.23 | 6,194 | 230,622 | 75,000 | 81.2 K to 75 K (-7.63 %) |
| Apr 07 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 36.38 | 5,456 | 198,463 | 81,194 | 86.7 K to 81.2 K (-6.30 %) |
| Mar 24 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 37.27 | 200 | 7,454 | 86,650 | 86.9 K to 86.7 K (-0.23 %) |
| Mar 24 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 36.59 | 18,587 | 680,180 | 86,850 | 105.4 K to 86.9 K (-17.63 %) |
| Mar 24 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 37.00 | 11,041 | 408,462 | 105,437 | 116.5 K to 105.4 K (-9.48 %) |
| Mar 24 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 37.75 | 8,279 | 312,517 | 116,478 | 124.8 K to 116.5 K (-6.64 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.02 | 13,234 | 529,611 | 181,489 | 194.7 K to 181.5 K (-6.80 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.02 | 2,717 | 108,737 | 194,723 | 197.4 K to 194.7 K (-1.38 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 39.37 | 200 | 7,874 | 197,440 | 197.6 K to 197.4 K (-0.10 %) |
| Mar 20 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 38.76 | 15,838 | 613,851 | 197,640 | 213.5 K to 197.6 K (-7.42 %) |
| Mar 10 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 39.94 | 7,304 | 291,702 | 124,757 | 132.1 K to 124.8 K (-5.53 %) |
| Mar 10 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 39.95 | 18,596 | 742,843 | 132,061 | 150.7 K to 132.1 K (-12.34 %) |
| Mar 10 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 39.78 | 10,992 | 437,211 | 150,657 | 161.6 K to 150.7 K (-6.80 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.78 | 4,230 | 172,512 | 213,478 | 217.7 K to 213.5 K (-1.94 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.08 | 15,586 | 624,746 | 217,708 | 233.3 K to 217.7 K (-6.68 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 41.02 | 8,500 | 348,662 | 233,294 | 241.8 K to 233.3 K (-3.52 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.78 | 31,591 | 1,288,306 | 241,794 | 273.4 K to 241.8 K (-11.56 %) |
| Mar 06 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 41.25 | 49,092 | 2,025,104 | 273,385 | 322.5 K to 273.4 K (-15.22 %) |
| Feb 27 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 38.10 | 4,444 | 169,328 | 161,649 | 166.1 K to 161.6 K (-2.68 %) |
| Feb 27 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 38.54 | 500 | 19,272 | 166,093 | 166.6 K to 166.1 K (-0.30 %) |
| Feb 27 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 38.13 | 27,902 | 1,063,842 | 166,593 | 194.5 K to 166.6 K (-14.35 %) |
| Feb 27 2017 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 38.57 | 5,505 | 212,351 | 194,495 | 200 K to 194.5 K (-2.75 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.36 | 2,933 | 118,369 | 322,477 | 325.4 K to 322.5 K (-0.90 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 39.83 | 7,426 | 295,794 | 325,410 | 332.8 K to 325.4 K (-2.23 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.67 | 7,204 | 292,981 | 332,836 | 340 K to 332.8 K (-2.12 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.75 | 38,343 | 1,562,489 | 340,040 | 378.4 K to 340 K (-10.13 %) |
| Feb 21 2017 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 40.23 | 9,057 | 364,379 | 378,383 | 387.4 K to 378.4 K (-2.34 %) |
| Nov 28 2016 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 32.00 | 93,750 | 3,000,000 | 0 | 93.8 K to 0 (-100.00 %) |
| Nov 28 2016 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Buy | P | 32.00 | 30,000 | 960,000 | 30,000 | 0 to 30 K |
| Nov 21 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.00 | 1,594,671 | 51,029,472 | 3,317,977 | 1.7 M to 3.3 M (+92.54 %) |
| Nov 21 2016 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | P | 32.00 | 165,824 | 5,306,368 | 355,198 | 189.4 K to 355.2 K (+87.56 %) |
| Nov 18 2016 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Option Exercise | A | 2.84 | 2,047,500 | 5,814,900 | 2,047,500 | |
| Nov 18 2016 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & CSO | Option Exercise | A | 2.84 | 1,752,500 | 4,977,100 | 1,752,500 | |
| Nov 18 2016 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Option Exercise | A | 2.84 | 1,613,430 | 4,582,141 | 1,613,430 | |
| Sep 30 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 31.16 | 11,300 | 352,108 | 0 | 11.3 K to 0 (-100.00 %) |
| Sep 30 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 30.47 | 30,163 | 919,067 | 11,300 | 41.5 K to 11.3 K (-72.75 %) |
| Sep 28 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 29.63 | 26,483 | 784,691 | 41,463 | 67.9 K to 41.5 K (-38.98 %) |
| Sep 28 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 29.58 | 20,666 | 611,300 | 67,946 | 88.6 K to 67.9 K (-23.32 %) |
| Sep 26 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 30.77 | 11,433 | 351,793 | 88,612 | 100 K to 88.6 K (-11.43 %) |
| Sep 26 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 31.13 | 25,010 | 778,561 | 100,045 | 125.1 K to 100 K (-20.00 %) |
| Sep 21 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Gift | G | 0.00 | 3 | 0 | 4,881,997 | 4.9 M to 4.9 M (0.00 %) |
| Sep 21 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Gift | G | 0.00 | 250,000 | 0 | 4,882,000 | 5.1 M to 4.9 M (-4.87 %) |
| Sep 21 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 31.19 | 16,318 | 508,958 | 125,055 | 141.4 K to 125.1 K (-11.54 %) |
| Sep 21 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 31.01 | 8,243 | 255,615 | 141,373 | 149.6 K to 141.4 K (-5.51 %) |
| Sep 21 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 32.17 | 1,900 | 61,123 | 149,616 | 151.5 K to 149.6 K (-1.25 %) |
| Sep 21 2016 | BGNE | BeiGene, Ltd. | Glazer Donald W. | Director | Sell | S | 31.56 | 40,791 | 1,287,364 | 151,516 | 192.3 K to 151.5 K (-21.21 %) |
| Sep 07 2016 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | A | 2.27 | 1,400,000 | 3,178,000 | 1,400,000 | |
| Sep 07 2016 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Aug 24 2016 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Option Exercise | A | 2.24 | 1,600,000 | 3,584,000 | 1,600,000 | |
| Aug 24 2016 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Jul 15 2016 | BGNE | BeiGene, Ltd. | Yang Jianxin | Sr. VP, Head of Cli ... | Option Exercise | A | 2.29 | 825,000 | 1,889,250 | 825,000 | |
| Jul 15 2016 | BGNE | BeiGene, Ltd. | Li Ji | EVP and Gl. Head of ... | Option Exercise | A | 2.29 | 260,000 | 595,400 | 260,000 | |
| Jul 15 2016 | BGNE | BeiGene, Ltd. | Yan Wendy Xiaojun | Sr. VP, Head of Reg ... | Option Exercise | A | 2.29 | 825,000 | 1,889,250 | 825,000 | |
| May 05 2016 | BGNE | BeiGene, Ltd. | Li Ji | EVP and Gl. Head of ... | Option Exercise | A | 2.05 | 2,376,000 | 4,870,800 | 2,376,000 | |
| May 05 2016 | BGNE | BeiGene, Ltd. | Li Ji | EVP and Gl. Head of ... | Grant | A | 0.00 | 475,000 | 0 | 475,000 | 0 to 475 K |
| Feb 10 2016 | BGNE | BeiGene, Ltd. | Merck & Co., Inc. | 10% Owner | Option Exercise | C | 0.00 | 5,128,205 | 0 | 0 | |
| Feb 10 2016 | BGNE | BeiGene, Ltd. | Merck & Co., Inc. | 10% Owner | Option Exercise | C | 0.00 | 18,518,519 | 0 | 0 | |
| Feb 10 2016 | BGNE | BeiGene, Ltd. | Merck & Co., Inc. | 10% Owner | Buy | J | 0.00 | 7,942,314 | 0 | 7,942,314 | 0 to 7.9 M |